Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Prevalence of non-alcoholic fatty liver disease in apparently healthy blood bank donors: metabolic, alcohol, and combined damage
JE Lira-Vera; O Morales-Gutiérrez; FY Vargas-Durán; P Alagón-Fernández del Campo; AK Soto Martínez; D Montemira-Orozco; A Burak-Leipuner; C Hinojosa-Segura; G Gutiérrez-Reyes; M Martínez-Castillo; S Sánchez-Valle; MA Lemus-Peña; D Montes de Oca-Ángeles; A Hernández-Barragán; M Hernández-Santillán; MF Higuera-de la Tijera; YL Béjar-Ramírez; JL Pérez-Hernández;
Ann Hepatol. 2022;27 Supl 3:
Prevalence of high-risk non-alcoholic steatohepatitis according to the fast® index in a group of diabetic patients
A Burak-Leipuner; F Higuera-de la Tijera; A Servín-Caamaño; J Romero-Bermúdez; L Ceceña-Martínez; F García-Gorrosquieta; N Uribe-Rivera; P Alagón-Fernández del Campo; F Vargas-Duran; C Hinojosa-Segura; D Montemira-Orozco; JL Pérez-Hernández;
Ann Hepatol. 2022;27 Supl 3:
Evaluation of IL-12 and CXCL-10 in patients with hepatitis C, non-alcoholic fatty liver disease and liver damage for alcohol consumption
M Hernandez-Santillan; M Martínez-Castillo; Z Medina-Ávila; M Lemus-Peña; D Montes de Oca-Ángeles; A Hernández-Barragan; JL Pérez-Hernández; F Higuera-De la Tijera; D Santana-Vargas; P Cordero-Pérez; L Muñoz-Espinoza; J Córdova-Gallardo; D Kershenobich; G Gutiérrez-Reyes;
Ann Hepatol. 2022;27 Supl 3: